期刊文献+

Podoplanin及CD34在脉管畸形中表达的意义 被引量:3

Podoplanin and CD34 Expression on Oral Vascular Malformation
原文传递
导出
摘要 目的:探讨Podoplanin及CD34在口腔颌面部脉管畸形诊断中的意义。方法:收集30例病理诊断为脉管畸形的标本,进行HE染色,采用免疫组织化学方法观察Podoplanin和CD34的表达。结果:Podoplanin和CD34双重染色结果显示,淋巴管对Podoplanin有较好的阳性表达,呈现深褐色;而毛细血管对CD34有较好的阳性表达,呈现蓝色。结论:Podoplanin和CD34双重染色,在畸形血管和淋巴管中有较好的表达,能够辨别脉管畸形中的毛细淋巴管和毛细血管,可以作为组织学诊断的辅助。 Objective:To discuss the significance of Podoplanin and CD34in the diagnosis of oral vascular malformation.Methods:Eighteen specimens with oral vascular malformation were studied with HE stain,Podoplanin stain,and CD34 stain respectively.Results:After Podoplanin and CD34double staining,Podoplanin was positively expressed in lymphatic vessels and stained puce,while CD34 was positively expressed in capillary vessels and stained blue.Conclusion:It is easier to distinguish capillary vessel,and capillary lymphatic vessel when use double stains technique of Podoplanin and CD34.Podoplanin and CD34 gain well expression in malformation capillary lymphatic vessel and capillary vessel and the Podoplanin-CD34 double stains technique can be used to enhance the veracity of pathological diagnosis.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2010年第6期804-806,860,共4页 Medical Journal of Wuhan University
基金 湖北省卫生厅资助项目(编号:JX3B25) 湖北省自然科学基金资助项目(编号:2006ABA249)
关键词 组织化学 脉管畸形 PODOPLANIN CD34 Histochemistry Oral Vascular Malformation Podoplanin CD34
  • 相关文献

参考文献11

  • 1张莉,林晓曦,王炜.血管瘤和血管畸形的鉴别诊断[J].中华整形外科杂志,2003,19(2):138-141. 被引量:54
  • 2Dubois J,Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group[J]. J Pediatr Padid, 1999,29:879-893.
  • 3刘斌,张文峰,赵怡芳.口腔颌面部淋巴管畸形的VEGF-C和VEGFR-3表达[J].口腔医学研究,2004,20(4):389-391. 被引量:3
  • 4Breiteneder-Geleff S, Matsui K,Soleiman A, et al. Podoplanin ,a novel 43-kd membrane protein of glomeru lar epithetlial cells, is down-regulated in puromycin ne phrosis[J]. Am J Pathol, 1997,151:1 141-1 152.
  • 5Breiteneder-Geleft S,Soleiman A,Kowaslki H. Angiosareomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium[J]. Am J Pathol, 1999,152(2) :385-394.
  • 6Wetterwalda A, Hoffstetter W, Cecchini MG, et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes[J]. Bone, 1996, 18: 125-132.
  • 7Petrova TV, Makinen T, Makela TP, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor[J]. EMBO J, 2002,21:4 593-4 599.
  • 8Hirakawa S, Hong YK, Harvey N, et al. Transcriptional profiling of isolated human lymphatic versus blood vascular endothelial cells [ J]. Am J Pathol, 2003,162: 575-586.
  • 9Kyzas PA,Geleff S,Batistatou A, et al. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma[J]. J Pathol, 2005, 206(2): 170-177.
  • 10Adhemar LF,Tiago GO, Celine P, et al. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis[J]. World J Surgical Oncology,2007, 5: 140-144.

二级参考文献13

  • 1张文峰,钟林生.平阳霉素瘤内注射治疗颌面部血管瘤[J].口腔医学纵横,1995,11(2):100-101. 被引量:30
  • 2Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. Embo J, 1997, 16(13)∶3 898-3 911
  • 3Claesson-Welsh L. Vascular growth factors and angiogenesis. Berlin: Springer-Verlag,1999,89
  • 4Shibuya M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv Cancer Res, 1995, 67∶281-316
  • 5Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol, 1995, 129(4)∶895-898
  • 6Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA, 1998, 95(2)∶548-553
  • 7Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem, 1992, 267(36)∶2 6031-2 6037
  • 8Kukk E, Lymboussaki A, Taira S, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 1996, 122(12)∶3 829-3 837
  • 9董长宪,李恭才,张宪生,徐泉,高亚,苏宝山.碱性纤维母细胞生长因子在血管瘤及血管畸形中的表达[J].中华小儿外科杂志,1997,18(6):322-324. 被引量:14
  • 10林晓曦,王炜,钱文牛,韩忠镕,董佳生,祁佐良,张涤生.增殖细胞核抗原在血管瘤及血管畸形组织中的表达[J].中华整形烧伤外科杂志,1998,14(1):19-22. 被引量:20

共引文献55

同被引文献19

  • 1LEE B B, BAUMGARTNER I, BERLIEN H P, et al. Consen- sus document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio- venous management [J]. Int Angiol, 2013, 32(1): 9-36.
  • 2BLAISE S, CHARAVIN-COCUZZA M, RIOM H, et al. Treatment of low-flow vascular malformations by ultra- sound-guided sclerotherapy with polidocanol foam: 24 cas- es and literature review[J]. Eur J Vasc Endovasc Surg, 2011, 41(3): 412-417.
  • 3GORR1Z-GOMEZ E, VICENTE-BARRERO M, LORAS- CABALLERO M L, et al. Sclerotherapy of face and oral cavity low flow vascular malformations: our experience[J]. Br J Oral Maxillofac Surg, 2014, 52(1): 43-47.
  • 4ERGUN O, ATLI E, GULEK B, et al. Intraarterial poli- docanol injection for the treatment of peripheral arteriove- nous malformations[J]. Surg Today, 2014, 44(7): 1232-1241.
  • 5ROSEN R J, NASSIRI N, DRURY J E. Interventional man- agement of high-flow vascular malformations[J]. Tech Vasc Interv Radiol, 2013, 16(1): 22-38.
  • 6CHO S K, DO Y S, SHIN S W, et al. Arteriovenous mal- formations of the body and extremities: analysis of therapeu- tic outcomes and approaches according to a modified angio- graphic classification[J]. J Endovasc Ther, 2006, 13(4): 527- 538.
  • 7DO Y S, YAKES W F, SHIN S W, et al. Ethanol emboliza- tion of arteriovenous malformations: interim results[J]. Ra- diology, 2005, 235(2): 674-682.
  • 8VAN DER LINDEN E, VAN BAALEN J M, PATTYNAMA P M. Retrograde transvenous ethanol embolization of high- flow peripheral arteriovenous malformations[J]. Cardiovasc Intervent Radiol, 2012, 35(4): 820-825.
  • 9DO S, KIM Y W, PARK K B, et al. Endovascular treat- ment combined with emboloscleorotherapy for pelvic arte- riovenous malformations[J]. J Vasc Surg, 2012, 55(2): 465- 471.
  • 10LEE J J, DO Y S, KIM J A. Serum ethanol levels after alco- hol sclerotherapy of arteriovenous malformations[J]. J Kore- an Med Sci, 2004, 19(1): 51-54.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部